$REFI
Chicago Atlantic Real Estate Finance, Inc.

2023 Q3 Form 10-Q Financial Statement

#000121390023064752 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $15.18M $13.66M $15.99M
YoY Change 17.37% 19.86% 176.74%
Cost Of Revenue $1.450M $994.9K $1.231M
YoY Change 68.34% 121.31%
Gross Profit $13.73M $13.66M $14.76M
YoY Change 6.16% 19.86%
Gross Profit Margin 90.45% 100.0% 92.3%
Selling, General & Admin $3.880M $3.882M $5.023M
YoY Change 35.76% 34.27% 327.98%
% of Gross Profit 28.26% 28.41% 34.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.840M $5.021M $7.507M
YoY Change 21.34% 27.54% 442.01%
Operating Profit $9.890M $8.643M $7.256M
YoY Change 1.24% 15.8%
Interest Expense $1.449M $871.4K
YoY Change 102.64% 215.09%
% of Operating Profit 14.65% 10.08%
Other Income/Expense, Net $1.280M
YoY Change 64.74%
Pretax Income $9.977M $8.643M $7.256M
YoY Change 2.13% 15.8% 66.4%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $9.977M $8.643M $7.256M
YoY Change 2.13% 15.8% 66.4%
Net Earnings / Revenue 65.72% 63.26% 45.37%
Basic Earnings Per Share $0.55 $0.48
Diluted Earnings Per Share $0.54 $0.47 $0.41
COMMON SHARES
Basic Shares Outstanding 18.18M shares 18.09M shares 17.66M shares
Diluted Shares Outstanding 18.56M shares 18.27M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.700M $18.02M $5.716M
YoY Change -6.77% 172.09% -92.88%
Cash & Equivalents $8.702M $18.02M $5.716M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $994.8K $1.204M
Prepaid Expenses
Receivables
Other Receivables $3.285M $100.4K
Total Short-Term Assets $12.90M $19.27M $6.734M
YoY Change 26.77% 154.23% -91.61%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.500M $877.6K
YoY Change
Other Assets -$5.100M -$5.122M -$3.941M
YoY Change -554.01%
Total Long-Term Assets $339.4M $311.3M $336.5M
YoY Change 2.76% -5.66% 70.04%
TOTAL ASSETS
Total Short-Term Assets $12.90M $19.27M $6.734M
Total Long-Term Assets $339.4M $311.3M $336.5M
Total Assets $352.3M $330.6M $343.3M
YoY Change 3.47% -2.07% 23.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.200M $1.416M $1.058M
YoY Change 67.49% 165.25% 397.03%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $315.6M $336.3M
YoY Change -4.94% 67.86%
Total Short-Term Liabilities $11.40M $11.92M $17.97M
YoY Change 8.58% -29.1% 217.76%
LONG-TERM LIABILITIES
Long-Term Debt $63.00M $43.00M $58.00M
YoY Change 18.87% -4.44%
Other Long-Term Liabilities $2.200M $1.944M $3.266M
YoY Change -67.78% -72.66% -61.29%
Total Long-Term Liabilities $65.20M $44.94M $61.27M
YoY Change 8.98% -13.75% 626.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.40M $11.92M $17.97M
Total Long-Term Liabilities $65.20M $44.94M $61.27M
Total Liabilities $76.52M $56.87M $79.24M
YoY Change 8.81% -17.5% 462.27%
SHAREHOLDERS EQUITY
Retained Earnings -$1.343M -$2.898M -$5.140M
YoY Change -223.47% 720.77% 2794.62%
Common Stock $277.1M $181.8K $176.9K
YoY Change 156842.75% 2.93% 1.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $275.8M $273.7M $264.0M
YoY Change
Total Liabilities & Shareholders Equity $352.3M $330.6M $343.3M
YoY Change 3.47% -2.07% 23.4%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income $9.977M $8.643M $7.256M
YoY Change 2.13% 15.8% 66.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $1.000M $10.21M $4.627M
YoY Change -80.01% 135.32% -183.04%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$21.71M $5.198M -$4.519M
YoY Change 987.95% -112.51% -91.07%
Cash From Investing Activities -$21.71M $5.198M -$4.519M
YoY Change 987.95% -112.51% -91.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.38M -2.029M -3.724M
YoY Change -3903.22% -105.37% -102.91%
NET CHANGE
Cash From Operating Activities 1.000M 10.21M 4.627M
Cash From Investing Activities -21.71M 5.198M -4.519M
Cash From Financing Activities 11.38M -2.029M -3.724M
Net Change In Cash -9.330M 13.38M -3.616M
YoY Change -444.48% 2355.37% -105.05%
FREE CASH FLOW
Cash From Operating Activities $1.000M $10.21M $4.627M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 refi Risk Rating Four
RiskRatingFour
usd
CY2020Q4 refi Risk Rating Four
RiskRatingFour
usd
CY2020Q2 refi Risk Rating Five
RiskRatingFive
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
refi Total Loans Held At Carrying Value Carrying Value
TotalLoansHeldAtCarryingValueCarryingValue
309415323 usd
CY2022Q4 us-gaap Principal Amount Outstanding On Loans Managed And Securitized
PrincipalAmountOutstandingOnLoansManagedAndSecuritized
343029334 usd
CY2022 refi Total Loans Held At Carrying Value Carrying Value
TotalLoansHeldAtCarryingValueCarryingValue
335332599 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41123
dei Entity Registrant Name
EntityRegistrantName
CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3125132
dei Entity Address Address Line1
EntityAddressAddressLine1
1680 Michigan Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33139
dei City Area Code
CityAreaCode
(312)
dei Local Phone Number
LocalPhoneNumber
809-7002
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
REFI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18175393 shares
CY2023Q2 refi Loans Held For Investment
LoansHeldForInvestment
314536900 usd
CY2022Q4 refi Loans Held For Investment
LoansHeldForInvestment
339273538 usd
CY2023Q2 refi Current Expected Credit Loss Reserve
CurrentExpectedCreditLossReserve
-5121577 usd
CY2022Q4 refi Current Expected Credit Loss Reserve
CurrentExpectedCreditLossReserve
-3940939 usd
CY2023Q2 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
309415323 usd
CY2022Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
335332599 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18020688 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5715827 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
877610 usd
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
994812 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1204412 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
1010720 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1018212 usd
CY2023Q2 refi Related Party Receivables
RelatedPartyReceivables
237885 usd
CY2023Q2 us-gaap Assets
Assets
330557038 usd
CY2022Q4 us-gaap Assets
Assets
343271050 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
43000000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
58000000 usd
CY2023Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
8708161 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
13618591 usd
CY2023Q2 us-gaap Management Fee Payable
ManagementFeePayable
1799667 usd
CY2022Q4 us-gaap Management Fee Payable
ManagementFeePayable
3295600 usd
CY2023Q2 refi Related Party Payables
RelatedPartyPayables
1601773 usd
CY2022Q4 refi Related Party Payables
RelatedPartyPayables
1397515 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1415612 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1058128 usd
CY2023Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
341951 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1868193 usd
CY2023Q2 us-gaap Liabilities
Liabilities
56867164 usd
CY2022Q4 us-gaap Liabilities
Liabilities
79238027 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18175393 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18175393 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17766936 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17766936 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
181754 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
176859 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
276405754 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
268995848 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2897634 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5139684 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
273689874 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
264033023 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
330557038 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
343271050 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14659222 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11850028 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
31186526 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
21683081 usd
CY2023Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-994926 usd
CY2022Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-449556 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-2613222 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-521824 usd
CY2023Q2 us-gaap Revenues
Revenues
13664296 usd
CY2022Q2 us-gaap Revenues
Revenues
11400472 usd
us-gaap Revenues
Revenues
28573304 usd
us-gaap Revenues
Revenues
21161257 usd
CY2023Q2 us-gaap Incentive Fee Expense
IncentiveFeeExpense
1799667 usd
CY2022Q2 us-gaap Incentive Fee Expense
IncentiveFeeExpense
1247561 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
3937672 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
1919066 usd
CY2023Q2 us-gaap Other Expenses
OtherExpenses
1280401 usd
CY2022Q2 us-gaap Other Expenses
OtherExpenses
777212 usd
us-gaap Other Expenses
OtherExpenses
2555226 usd
us-gaap Other Expenses
OtherExpenses
1333353 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
537894 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
743670 usd
us-gaap Professional Fees
ProfessionalFees
1107269 usd
us-gaap Professional Fees
ProfessionalFees
1300574 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
263844 usd
us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
17098254 usd
us-gaap Net Income Loss
NetIncomeLoss
19335727 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
273689874 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
269384516 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
122732 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2022Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
8343576 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
7463839 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.87
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
122525 usd
us-gaap Share Based Compensation
ShareBasedCompensation
402179 usd
us-gaap Share Based Compensation
ShareBasedCompensation
243465 usd
CY2023Q2 refi Provision For Current Expected Credit Losses
ProvisionForCurrentExpectedCreditLosses
1139112 usd
CY2022Q2 refi Provision For Current Expected Credit Losses
ProvisionForCurrentExpectedCreditLosses
1045665 usd
refi Provision For Current Expected Credit Losses
ProvisionForCurrentExpectedCreditLosses
1235231 usd
refi Provision For Current Expected Credit Losses
ProvisionForCurrentExpectedCreditLosses
1097008 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
5020918 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3936633 usd
us-gaap Operating Expenses
OperatingExpenses
9237577 usd
us-gaap Operating Expenses
OperatingExpenses
5893466 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8643378 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7463839 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19335727 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15267791 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8643378 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
7463839 usd
us-gaap Net Income Loss
NetIncomeLoss
19335727 usd
us-gaap Net Income Loss
NetIncomeLoss
15267791 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18094288 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17657913 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17989684 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17649548 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18273512 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17752413 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18117919 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17745234 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
272123328 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1222352 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
263844 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2023Q2 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
8563028 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8643378 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
273689874 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
264033023 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1222352 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5794847 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
402179 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
268627511 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
264077968 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4481556 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
244647 usd
us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
15444451 usd
us-gaap Net Income Loss
NetIncomeLoss
15267791 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
268627511 usd
us-gaap Net Income Loss
NetIncomeLoss
19335727 usd
us-gaap Net Income Loss
NetIncomeLoss
15267791 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1433293 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1362776 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
4345434 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2400627 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1235231 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1097008 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
259102 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
241095 usd
us-gaap Share Based Compensation
ShareBasedCompensation
402179 usd
us-gaap Share Based Compensation
ShareBasedCompensation
243465 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-209600 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
777837 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
119819 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
146102 usd
refi Increase Decrease In Interest Reserves
IncreaseDecreaseInInterestReserves
-1526242 usd
refi Increase Decrease In Interest Reserves
IncreaseDecreaseInInterestReserves
-6162392 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
204258 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
739950 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
237885 usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
877610 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1495933 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
342438 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
302891 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
292669 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11912772 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7374682 usd
refi Issuance Of And Fundings Of Loans Held For Investment
IssuanceOfAndFundingsOfLoansHeldForInvestment
34791660 usd
refi Issuance Of And Fundings Of Loans Held For Investment
IssuanceOfAndFundingsOfLoansHeldForInvestment
125383782 usd
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
13399712 usd
refi Proceeds From Repayment Of Loan To Purchase Common Stock
ProceedsFromRepaymentOfLoanToPurchaseCommonStock
51907313 usd
refi Proceeds From Repayment Of Loan To Purchase Common Stock
ProceedsFromRepaymentOfLoanToPurchaseCommonStock
6654703 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
30515365 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-118729079 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7222363 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4505664 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
34000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
45000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
49000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
22004274 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
11575495 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
56791 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
177261 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
284574 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
23941 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30123276 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
37728967 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
12304861 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-73625430 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5715827 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80248526 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18020688 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6623096 usd
refi Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
5895863 usd
refi Oid Withheldfrom Funding Of Loans
OIDWithheldfromFundingOfLoans
1118340 usd
refi Oid Withheldfrom Funding Of Loans
OIDWithheldfromFundingOfLoans
1835592 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8708161 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8380271 usd
refi Transfer Of Loan Held For Investment To Loan Held For Sale
TransferOfLoanHeldForInvestmentToLoanHeldForSale
13399712 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
2442866 usd
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
102500 usd
refi Least Percentage Of Taxable Income
LeastPercentageOfTaxableIncome
0.90 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates in the Preparation of Consolidated Financial Statements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.</span></p>
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Interest income on debt securities designated as trading securities is recognized on an accrual basis and is reported as interest receivable until collected. Interest income is accrued based on the outstanding face amount and the contractual terms of the securities. Original issue discount (“OID”), market discounts or premiums, if any, are recorded as an adjustment to the amortized cost and accreted or amortized as an adjustment to interest income using a method that approximates the effective interest method. </p>
refi Least Percentage
LeastPercentage
0.90 pure
refi Taxable Income Percentage
TaxableIncomePercentage
1 pure
refi Ordinary Income Percentage
OrdinaryIncomePercentage
0.85 pure
CY2023Q2 us-gaap Derivative Net Assets Percentage
DerivativeNetAssetsPercentage
0.95 pure
us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.04 pure
CY2023Q2 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.90 pure
us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.04 pure
us-gaap Loan Portfolio Expense
LoanPortfolioExpense
25 usd
CY2022 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
22 usd
CY2023Q2 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
329200000 usd
CY2022Q4 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
318000000 usd
CY2023Q2 us-gaap Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
351400000 usd
CY2022Q4 us-gaap Fair Value Option Loans Held As Assets Aggregate Difference
FairValueOptionLoansHeldAsAssetsAggregateDifference
343000000 usd
CY2023Q2 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
1900000 usd
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
35900000 usd
CY2023Q2 refi Portfolio Percentage
PortfolioPercentage
0.879 pure
CY2022Q4 refi Portfolio Percentage
PortfolioPercentage
0.831 pure
CY2023Q2 refi Loan Carrying Value
LoanCarryingValue
276200000 usd
CY2022Q4 refi Loan Carrying Value
LoanCarryingValue
281600000 usd
CY2023Q2 refi Remaining Portfolio Percentage
RemainingPortfolioPercentage
0.121 pure
CY2022Q4 refi Remaining Portfolio Percentage
RemainingPortfolioPercentage
0.169 pure
CY2023Q2 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
38300000 usd
CY2022Q4 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
57700000 usd
CY2023Q2 us-gaap Principal Amount Outstanding On Loans Managed And Securitized
PrincipalAmountOutstandingOnLoansManagedAndSecuritized
317977743 usd
refi Total Loans Held At Carrying Value Original Issue Discount
TotalLoansHeldAtCarryingValueOriginalIssueDiscount
-3440843 usd
CY2022 refi Total Loans Held At Carrying Value Original Issue Discount
TotalLoansHeldAtCarryingValueOriginalIssueDiscount
-3755796 usd
CY2023Q2 us-gaap Other Commitment
OtherCommitment
329174423 usd
refi Outstanding Principal
OutstandingPrincipal
317977743 usd
refi Original Issue Premium Discount
OriginalIssuePremiumDiscount
-3440843 usd
CY2023Q2 refi Debt Instrument Carrying Value
DebtInstrumentCarryingValue
309415323 usd
refi Percent Of Our Loan Portfolio
PercentOfOurLoanPortfolio
1 pure
refi Future Fundings
FutureFundings
13604000 usd
us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
Wtd Average
refi Yieldto Maturityof Internal Rateof Return
YieldtoMaturityofInternalRateofReturn
0.192 pure
refi Prime Rate Floor
PrimeRateFloor
0.0325 pure
refi Prime Rate Floor Two
PrimeRateFloorTwo
0.0475 pure
refi Prime Rate Floor Three
PrimeRateFloorThree
0.055 pure
refi Prime Rate Floor Four
PrimeRateFloorFour
0.0625 pure
refi Prime Rate Floor Five
PrimeRateFloorFive
0.07 pure
refi Prime Rate Floor Six
PrimeRateFloorSix
0.075 pure
refi Prime Rate Floor Seven
PrimeRateFloorSeven
0.08 pure
refi Prime Rate Floor Eight
PrimeRateFloorEight
0.0825 pure
refi Prime Rate Floor Nine
PrimeRateFloorNine
0.0585 pure
CY2023Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.02 pure
refi Aggregate Commitment
AggregateCommitment
50000000 usd
CY2023Q3 refi Advance Loan
AdvanceLoan
18700000 usd
CY2023Q2 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
309852814 usd
CY2022Q4 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
329237824 usd
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
4684085 usd
CY2022Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
10035714 usd
CY2023Q2 us-gaap Additional Liability Long Duration Insurance Current Weighted Average Discount Rate
AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate
0.1631 pure
CY2023Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
309852814 usd
refi Primary Valuation Techniques
PrimaryValuationTechniques
Yield analysis
us-gaap Fair Value Measurements Sensitivity Analysis Description
FairValueMeasurementsSensitivityAnalysisDescription
Market yield
CY2023Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.1631 pure
CY2023Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
309852814 usd
CY2023Q2 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
314536900 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
314536900 usd
CY2023Q2 refi Risk Rating One
RiskRatingOne
10515420 usd
CY2022Q2 refi Risk Rating One
RiskRatingOne
30113057 usd
CY2021Q2 refi Risk Rating One
RiskRatingOne
196005 usd
CY2021Q4 refi Risk Rating One
RiskRatingOne
274406 usd
CY2023Q2 refi Risk Rating Two
RiskRatingTwo
2874319 usd
CY2022Q2 refi Risk Rating Two
RiskRatingTwo
102663294 usd
CY2021Q2 refi Risk Rating Two
RiskRatingTwo
66147544 usd
CY2022Q4 refi Risk Rating Two
RiskRatingTwo
94467449 usd
CY2021Q4 refi Risk Rating Two
RiskRatingTwo
88444868 usd
CY2020Q4 refi Risk Rating Two
RiskRatingTwo
29140546 usd
CY2022Q2 refi Risk Rating Three
RiskRatingThree
5085794 usd
CY2021Q2 refi Risk Rating Three
RiskRatingThree
55859471 usd
CY2022Q4 refi Risk Rating Three
RiskRatingThree
30415113 usd
CY2021Q4 refi Risk Rating Three
RiskRatingThree
83131444 usd
CY2021Q2 refi Risk Rating Four
RiskRatingFour
41081996 usd
CY2021Q4 refi Risk Rating Four
RiskRatingFour
13399712 usd
CY2023Q2 refi Risk Rating
RiskRating
13389739 usd
CY2022Q2 refi Risk Rating
RiskRating
137862145 usd
CY2021Q2 refi Risk Rating
RiskRating
163285016 usd
CY2022Q4 refi Risk Rating
RiskRating
124882562 usd
CY2021Q4 refi Risk Rating
RiskRating
185250430 usd
CY2020Q4 refi Risk Rating
RiskRating
29140546 usd
CY2022Q4 refi Interest Reserves
InterestReserves
1868193 usd
CY2021Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
10000000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4035354 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1235231 usd
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5270585 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
147949 usd
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
1097008 usd
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1244957 usd
CY2023Q2 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
994812 usd
CY2022Q4 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
1204412 usd
CY2023Q2 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
944007 usd
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
1203330 usd
CY2023Q2 refi Unused Fee Receivable
UnusedFeeReceivable
50805 usd
CY2022Q4 refi Unused Fee Receivable
UnusedFeeReceivable
1082 usd
CY2023Q2 refi Total Interest Receivable
TotalInterestReceivable
994812 usd
CY2022Q4 refi Total Interest Receivable
TotalInterestReceivable
1204412 usd
CY2023Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
994812 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
994812 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1204412 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1204412 usd
CY2023Q2 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
16200000 usd
CY2023Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
0 usd
CY2022Q4 refi Interest Reserves
InterestReserves
1868193 usd
CY2021Q4 refi Interest Reserves
InterestReserves
6636553 usd
refi New Reserves
NewReserves
446212 usd
CY2022 refi New Reserves
NewReserves
9049834 usd
refi Reserve Disbursed
ReserveDisbursed
-1972454 usd
CY2022 refi Reserve Disbursed
ReserveDisbursed
-13818194 usd
CY2023Q2 refi Interest Reserves
InterestReserves
341951 usd
CY2021Q2 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
100000 usd
CY2021Q4 us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
CAL entered into an amended and restated Revolving Loan agreement (the “First Amendment and Restatement”). The First Amendment and Restatement increased the loan commitment from $10,000,000 to $45,000,000 and decreased the interest rate, from the greater of the (1) Prime Rate plus 1.00% and (2) 4.75% to the greater of (1) the Prime Rate plus the applicable margin and (2) 3.25%. The applicable margin is derived from a floating rate grid based upon the ratio of debt to equity of CAL and increases from 0% at a ratio of 0.25 to 1 to 1.25% at a ratio of 1.5 to 1. The First Amendment and Restatement also extended the maturity date from February 12, 2023 to the earlier of (i) December 16, 2023 and (ii) the date on which the Revolving Loan is terminated pursuant to the terms of the Revolving Loan agreement.
CY2021Q4 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
859500 usd
CY2022Q2 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
177261 usd
CY2022Q4 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
323779 usd
CY2023Q2 us-gaap Accumulated Amortization Of Debt Issuance Costs Line Of Credit Arrangements
AccumulatedAmortizationOfDebtIssuanceCostsLineOfCreditArrangements
2988 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
109291 usd
us-gaap Long Term Debt Description
LongTermDebtDescription
Additionally, the Company must comply with certain financial covenants including: (1) maximum capital expenditures of $150,000, (2) maintaining a debt service coverage ratio greater than 1.35 to 1, and (3) maintaining a leverage ratio less than 1.50 to 1. As of June 30, 2023, the Company is in compliance with all financial covenants with respect to the Revolving Loan.
CY2023Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
662938 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
805596 usd
us-gaap Proceeds Of Other Loans And Leases Held For Investment
ProceedsOfOtherLoansAndLeasesHeldForInvestment
279229247 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
871428 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
276562 usd
us-gaap Interest Expense
InterestExpense
2312420 usd
us-gaap Interest Expense
InterestExpense
276562 usd
CY2023Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
31701 usd
CY2022Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4167 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
41701 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4167 usd
CY2023Q2 refi Amortization Of Debt Issue Costs1
AmortizationOfDebtIssueCosts1
91797 usd
CY2022Q2 refi Amortization Of Debt Issue Costs1
AmortizationOfDebtIssueCosts1
168827 usd
refi Amortization Of Debt Issue Costs1
AmortizationOfDebtIssueCosts1
259101 usd
refi Amortization Of Debt Issue Costs1
AmortizationOfDebtIssueCosts1
241095 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
994926 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
449556 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
2613222 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
521824 usd
refi Interest Percentage
InterestPercentage
0.00375 pure
refi Equity Percentage
EquityPercentage
0.50 pure
CY2023Q2 us-gaap Increase Decrease In Management And Incentive Fees Payable
IncreaseDecreaseInManagementAndIncentiveFeesPayable
125000 usd
us-gaap Increase Decrease In Management And Incentive Fees Payable
IncreaseDecreaseInManagementAndIncentiveFeesPayable
130000 usd
CY2022Q2 us-gaap Increase Decrease In Management And Incentive Fees Payable
IncreaseDecreaseInManagementAndIncentiveFeesPayable
364500 usd
us-gaap Increase Decrease In Management And Incentive Fees Payable
IncreaseDecreaseInManagementAndIncentiveFeesPayable
1082251 usd
CY2023Q2 us-gaap Payment For Incentive Fee
PaymentForIncentiveFee
874854 usd
us-gaap Payment For Incentive Fee
PaymentForIncentiveFee
1986060 usd
CY2022Q2 us-gaap Payment For Incentive Fee
PaymentForIncentiveFee
598763 usd
us-gaap Payment For Incentive Fee
PaymentForIncentiveFee
980906 usd
CY2023Q2 us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
1049813 usd
CY2022Q2 us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
1013298 usd
us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
2081612 usd
us-gaap Property Management Fee Revenue
PropertyManagementFeeRevenue
2020411 usd
CY2023Q2 refi Other Fees Earned And Paid To The Manager
OtherFeesEarnedAndPaidToTheManager
-125000 usd
CY2022Q2 refi Other Fees Earned And Paid To The Manager
OtherFeesEarnedAndPaidToTheManager
-364500 usd
refi Other Fees Earned And Paid To The Manager
OtherFeesEarnedAndPaidToTheManager
-130000 usd
refi Other Fees Earned And Paid To The Manager
OtherFeesEarnedAndPaidToTheManager
-1082251 usd
CY2023Q2 refi Base Management Fees Net
BaseManagementFeesNet
924813 usd
CY2022Q2 refi Base Management Fees Net
BaseManagementFeesNet
648798 usd
refi Base Management Fees Net
BaseManagementFeesNet
1951612 usd
refi Base Management Fees Net
BaseManagementFeesNet
938160 usd
CY2023Q2 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
874854 usd
CY2022Q2 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
598763 usd
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
1986060 usd
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
980906 usd
CY2023Q2 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
-1799667 usd
CY2022Q2 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
-1247561 usd
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
-3937672 usd
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
-1919066 usd
CY2023Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1212210 usd
CY2022Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
686981 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2388586 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1151471 usd
CY2023Q2 us-gaap Affiliate Costs
AffiliateCosts
3011877 usd
CY2022Q2 us-gaap Affiliate Costs
AffiliateCosts
1934542 usd
us-gaap Affiliate Costs
AffiliateCosts
6326258 usd
us-gaap Affiliate Costs
AffiliateCosts
3070537 usd
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
3400000 usd
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
4700000 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
500000 usd
CY2023Q2 refi Right Amounting
RightAmounting
237885 usd
us-gaap Selling Expense
SellingExpense
14200000 usd
CY2023Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
13400000 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
800000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19300000 usd
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
19000000 usd
CY2023Q1 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
300000 usd
CY2023Q2 us-gaap Other Commitment
OtherCommitment
329174423 usd
CY2022Q4 us-gaap Other Commitment
OtherCommitment
351367706 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
315570423 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
336323706 usd
CY2023Q2 us-gaap Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
13604000 usd
CY2022Q4 us-gaap Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
15044000 usd
us-gaap Underwriting Commitments
UnderwritingCommitments
$50.0
CY2023Q2 refi Commitments Total
CommitmentsTotal
2400000 usd
CY2023Q2 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
50000000 usd
CY2023Q2 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
204000 usd
CY2023Q2 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
4000000 usd
CY2023Q2 us-gaap Other Commitment Due After Fifth Year
OtherCommitmentDueAfterFifthYear
56604000 usd
CY2022Q1 refi Underwriters Shares Purchase
UnderwritersSharesPurchase
302800 shares
CY2022Q1 refi Common Stock Price Par Value
CommonStockPriceParValue
16
CY2022Q1 refi Additional Gross Proceeds
AdditionalGrossProceeds
4844800 usd
CY2022Q1 refi Additional Net Proceeds
AdditionalNetProceeds
4505664 usd
CY2022Q1 refi Under Commissions
UnderCommissions
339136 usd
CY2023Q1 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
395779 shares
CY2023Q1 refi Common Stock Price Par Value
CommonStockPriceParValue
15.16
CY2023Q1 refi Additional Gross Proceeds
AdditionalGrossProceeds
6000000 usd
CY2021 refi Restricted Common Stock Shares
RestrictedCommonStockShares
98440 shares
refi Issued And Outstanding Shares Percentage
IssuedAndOutstandingSharesPercentage
0.085 pure
CY2022 refi Issued And Outstanding Shares Percentage
IssuedAndOutstandingSharesPercentage
0.085 pure
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
24880 shares
CY2023Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
321500 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
1147 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
4063 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
5871186 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
633861 usd
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
80984 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
321500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
13800 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1147 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
16
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
387537 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.9
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
98440 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4063 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
16
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
94377 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
402179 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
243465 usd
us-gaap Royalty Expense
RoyaltyExpense
5577827000000 usd
us-gaap Royalty Expense
RoyaltyExpense
1078216000000 usd
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
75000000 usd
CY2023Q2 refi Gross Proceeds Percentage
grossProceedsPercentage
0.03 pure
CY2023Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
8643378 usd
CY2022Q2 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
7463839 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
19335727 usd
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
15267791 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18094288 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17657913 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17989684 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17649548 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18273512 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17752413 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18117919 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17745234 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
refi Stockholders At Least Percentage
StockholdersAtLeastPercentage
0.90 pure
refi Reit Taxable Income Percentage
REITTaxableIncomePercentage
1 pure
refi Ordinary Income Percent
OrdinaryIncomePercent
0.85 pure
refi Capital Gain Net Income Percentage
CapitalGainNetIncomePercentage
0.95 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.04 pure
CY2023Q2 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.90 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.04 pure
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
0 usd
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
0 usd
us-gaap Debt Instrument Sinking Fund Payment
DebtInstrumentSinkingFundPayment
18700000 usd
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
50000000 usd
CY2023Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.47
us-gaap Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
8500000 usd
CY2022Q4 refi Related Party Receivables
RelatedPartyReceivables
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
usd
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
refi Interest Reserve Withheld From Funding Of Loan
InterestReserveWithheldFromFundingOfLoan
usd
CY2020Q2 refi Risk Rating One
RiskRatingOne
usd
CY2019Q2 refi Risk Rating One
RiskRatingOne
usd
CY2022Q4 refi Risk Rating One
RiskRatingOne
usd
CY2020Q4 refi Risk Rating One
RiskRatingOne
usd
CY2019Q4 refi Risk Rating One
RiskRatingOne
usd
CY2020Q2 refi Risk Rating Two
RiskRatingTwo
usd
CY2019Q2 refi Risk Rating Two
RiskRatingTwo
usd
CY2019Q4 refi Risk Rating Two
RiskRatingTwo
usd
CY2023Q2 refi Risk Rating Three
RiskRatingThree
usd
CY2020Q2 refi Risk Rating Three
RiskRatingThree
usd
CY2019Q2 refi Risk Rating Three
RiskRatingThree
usd
CY2020Q4 refi Risk Rating Three
RiskRatingThree
usd
CY2019Q4 refi Risk Rating Three
RiskRatingThree
usd
CY2023Q2 refi Risk Rating Four
RiskRatingFour
usd
CY2020Q2 refi Risk Rating Four
RiskRatingFour
usd
CY2019Q2 refi Risk Rating Four
RiskRatingFour
usd
CY2022Q4 refi Risk Rating Four
RiskRatingFour
usd
CY2019Q4 refi Risk Rating Four
RiskRatingFour
usd
CY2023Q2 refi Risk Rating Five
RiskRatingFive
usd
CY2022Q2 refi Risk Rating Five
RiskRatingFive
usd
CY2021Q2 refi Risk Rating Five
RiskRatingFive
usd
CY2019Q2 refi Risk Rating Five
RiskRatingFive
usd
CY2022Q4 refi Risk Rating Five
RiskRatingFive
usd
CY2021Q4 refi Risk Rating Five
RiskRatingFive
usd
CY2020Q4 refi Risk Rating Five
RiskRatingFive
usd
CY2019Q4 refi Risk Rating Five
RiskRatingFive
usd
CY2020Q2 refi Risk Rating
RiskRating
usd
CY2019Q2 refi Risk Rating
RiskRating
usd
CY2019Q4 refi Risk Rating
RiskRating
usd
CY2023Q2 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
usd
CY2023Q2 us-gaap Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001867949

Files In Submission

Name View Source Status
0001213900-23-064752-index-headers.html Edgar Link pending
0001213900-23-064752-index.html Edgar Link pending
0001213900-23-064752.txt Edgar Link pending
0001213900-23-064752-xbrl.zip Edgar Link pending
f10q0623ex10-8_chicagoatl.htm Edgar Link pending
f10q0623ex31-1_chicagoatl.htm Edgar Link pending
f10q0623ex31-2_chicagoatl.htm Edgar Link pending
f10q0623ex32-1_chicagoatl.htm Edgar Link pending
f10q0623ex32-2_chicagoatl.htm Edgar Link pending
f10q0623_chicagoatl.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0623_chicagoatl_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
refi-20230630.xsd Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
refi-20230630_def.xml Edgar Link unprocessable
refi-20230630_lab.xml Edgar Link unprocessable
refi-20230630_pre.xml Edgar Link unprocessable
refi-20230630_cal.xml Edgar Link unprocessable